Inflammation: Nutritional, botanical, and mind-body influences

Southern Medical Journal

Volumn 98, Issue 3, 2005, Pages 303-310

  Rakel, David P ^a   Rindfleisch, Adam ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

Botanicals; Essential fatty acids; Inflammation; Mindbody; Nutrition; Omega 3 fatty acids; Trans fatty acids

Indexed keywords

OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; TRANS FATTY ACID;

CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DIET; DISEASE ASSOCIATION; FAT INTAKE; FOOD INTAKE; FOOD PROCESSING; GLUCOSE BLOOD LEVEL; GLYCEMIC INDEX; GLYCEMIC LOAD; HEALTH CARE; HEART DISEASE; HUMAN; INFLAMMATION; MEDICAL RESEARCH; MEDITERRANEAN DIET; REVIEW; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION;

CHRONIC DISEASE; COMPLEMENTARY THERAPIES; DIET, MEDITERRANEAN; FATTY ACIDS; FATTY ACIDS, OMEGA-3; FATTY ACIDS, OMEGA-6; HUMANS; HYDROGENATION; INFLAMMATION; NUTRITION POLICY; PSYCHOPHYSIOLOGY; RISK FACTORS;

EID: 15044355912     PISSN: 00384348     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.SMJ.0000154775.16761.A9     Document Type: Review

References (52)

1. Ascherio A, Katan MB, Zock PL, et al. Trans fatty acids and coronary heart disease. N Engl J Med 1999;340:1994-1998.
2. Lichtenstein AH. Trans fatty acids, plasma lipid levels, and risk of developing cardiovascular disease: a statement for healthcare professionals from the American Heart Association. Circulation 1997;95:2588-2590.
3. Lopez-Garcia E, Schulze MB, Manson JE, et al. Consumption of (n-3) fatty acids is related to plasma biomarkers of inflammation and endothelial activation in women. J Nutr 2004;134:1806-1811.
4. Baer DJ, Judd JT, Clevidence BA, et al. Dietary fatty acids affect plasma markers of inflammation in healthy men fed controlled diets: a randomized crossover study. Am J Clin Nutr 2004;79:969-973.
5. Mozaffarian D, Pischon TT, Hankinson SE, et al. Dietary intake of trans fatty acids and systemic inflammation in women. Am J Clin Nutr 2004;79:606-612.
6. Stender S, Dyerberg J. Influence of trans fatty acids on health. Ann Nutr Metab 2004;48:61-66.
7. Food and Drug Administration. Food Labeling: Trans Fatty Acids in Nutrition Labeling, Nutrient Content Claims, and Health Claims. Federal Register: 68 FR 41433 July 11, 2003.
8. Vlassara H, Cai W, Crandall J, et al. Inflammatory mediators are induced by dietary glycotoxins, a major risk factor for diabetic angiography. Proc Natl Acad Sci 2002;99:15596-15601.
9. Dyerberg J, Bang HO, Hjorne N. Fatty acid composition of the plasma lipids in Greenland Eskimos. Am J Clin Nutr 1975;28:958-966.
10. Bang HO, Dyerberg J, Sinclair HM. The composition of the Eskimo food in northwestern Greenland. Am J Clin Nutr 1980;33:2657-2661.
11. Jho DH, Cole SM, Lee EM, et al. Role of omega-3- fatty acid supplementation in inflammation and malignancy. Integr Cancer Ther 2004;3:98-111.
12. Simopoulos AP. Omega-3 fatty acids in inflammation and auto-immune disease. J Am Coll Nutr 2002;21:495-505.
13. Babcock T, Helton WS, Espat NJ. Eicosapentaenoic acid (EPA): an anti-inflammatory omega-3 fat with potential clinical applications. Nutrilion 2000;16:1116-1118.
14. Jho DH, Babcock TA, Helton WS, et al. Omega-3 fatty acids: implication for the treatment of tumor associated inflammation. Am Surg 2003;69:32-36.
15. Obata T, Nagakura T, Masaki T, et al. Eicosapentaenoic acid inhibits prostaglandin D2 generation by inhibiting cyclo-oxygenase-2 in cultured human mast cells. Clin Exp Allergy 1999;29:1129-1135.
16. Ringbom T, Huss U, Stenholm A, et al. Cox-2 inhibitory effects of naturally occurring and modified fatty acids. J Nat Prod 2001;64:745-749.
17. Babcock TA, Helton WS, Hong D, et al. Omega-3 fatty acid lipid emulsion reduces LPS-stimulated macrophage TNF-alpha production. Surg Infect (Larchmt) 2002;3:145-149.
18. Novak TE, Babcock TA, Jho DH, et al. NF-kappa B inhibition by omega-3 fatty acids modulates LPS-stimulated macrophage TNF-alpha transcription. Am J Physiol Lung Cell Mol Physiol 2003;284:L84-L89.
19. Simopoulos AP. The importance of the ratio of omega-6/omega-3 essential fatty acids. Biomed Pharmacother 2002;56:365-379.
20. Johnson K. The glycemic index, in Rakel D (ed): Integrative Medicine. Philadelphia, WB Saunders, 2003, pp 661-666.
21. Foster-Powerll K, Holt SH, Barnd-Miller JC. International table of glycemic index and glycemic load values. Am J Clin Nutr 2002;76:55-56.
22. Wolever TM, David JA, Jenkins, et al. The glycemic index: methodology and clinical applications. Am J Clin Nutr 1991;54:846-854.
23. Wolever TM. The glycemic index: aspects of some vitamins, minerals, and enzymes in health and disease. World Rev Nutr Diet 1990;62:120-185.
24. Schulze MB, Liu S, Rimm EB, et al. Glycemic index, glycemic load, and dietary fiber intake and incidence of type 2 diabetes in younger and middle aged women. Am J Clin Nutr 2004;80:348-356.
25. Das UN. Is insulin an endogenous cardioprotector? Crit Care 2002;6:389-393.
26. Spranger J, Kroke A, Mohlig M, et al. Inflammatory cytokines and the risk to develop type 2 diabetes: results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC): Potsdam Study. Diabetes 2003;52:812-817.
27. Liu S, Manson JE, Buring JE, et al. Relation between a diet with a high glycemic load and plasma concentrations of high-sensitivity C-reactive protein in middle-aged women. Am J Clin Nutr 2002;75:492-498.
28. Liu S, Willett WC, Stampfer MJ, et al. A prospective study of dietary glycemic load, carbohydrate intake, and risk of coronary heart disease in US women. Am J Clin Nutr 2000;71:1455-1461.
29. Augustin LS, Gallus S, Negri E, et al. Glycemic index, glycemic load, and risk of gastric cancer. Ann Oncol 2004;15:581-584.
30. Higginbotham S, Zhang ZF, Lee IM, et al. Dietary glycemic load and risk of colorectal cancer in the Women's Health Study. J Natl Cancer Inst 2004;96:229-233.
31. Augustin LS, Gallus S, Franceschi S, et al. Glycemic index and load and risk of upper aero-digestive tract neoplasms. Cancer Causes Control 2003;14:657-662.
32. Folsom AR, Demissie Z, Harnack L. Glycemic index, glycemic load, and incidence of endometrial cancer: the Iowa Women's Health Study. Nutr Cancer 2003;46:119-124.
33. Michaud DS, Liu S, Giovannucci E, et al. Dietary sugar, glycemic load, and pancreatic cancer risk in a prospective study. J Natl Cancer Inst 2002;94:1293-1300.
34. Holmes MD, Liu S, Hankinson SE, et al. Dietary carbohydrates, fiber, and breast cancer risk. Am J Epidemiol 2004;159:732-739.
35. Chrysohoou C, Panagiotakos DB, Pitsavos C, et al. Adherence to the Mediterranean diet attenuates inflammation and coagulation process in healthy adults: the ATTICA study. J Am Coll Cardiol 2004;44:152-158.
36. Barzi F, Woodward M, Marfisi RM, et al. Mediterranean diet and all-causes mortality after myocardial infarction: results from the GISSI-Prevenzione trial. Eur J Clin Nutr 2003;57:604-611.
37. Marchioli R. Omega-3 polyunsaturated fatty acids and cardiovascular diseases. Minerva Cardioangiol 2003;51:561-576.
38. Augustine MB. Integrative approach to nutrition, in Kligler B, Lee R (eds): Integrative Medicine: Principles for Practice. New York, McGraw Hill, 2004.
39. Wallace JM. Nutritional and botanical modulation of the inflammatory cascade-eicosanoids, cyclooxygenases, and lipoxygenases-as an adjunct in cancer therapy. Integr Cancer Ther 2002;1:7-37.
40. Maes M, Christophe A, Bosnians E, et al. In humans, serum polyunsaturated fatty acid levels predict the response of proinflammatory cytokines to psychologic stress. Biol Psychiatry 2000;47:910-920.
41. Miller GE, Freedland KE, Carney RM, et al. Pathways linking depression, adiposity, and inflammatory markers in healthy young adults. Brain Behav Immun 2003;17:276-285.
42. Danner M, Kasl SV, Abramson JL, et al. Association between depression and elevated C-reactive protein. Psychosom Med 2003;65:347-356.
43. Ford DE, Erlinger TP. Depression and C-reactive protein in US adults: data from the Third National Health and Nutrition Examination Survey. Arch Intern Med 2004;164:1010-1014.
44. Panagiotakos DB, Pitsavos C, Chrysohoou C, et al. Inflammation, co-agulation, and depressive symptomatology in cardiovascular disease-free people: the ATTICA study. Eur Heart J 2004;25:492-499.
45. Yirmiya R. Depression in medical illness: the role of the immune system. West J Med 2000;173:333-336.
46. Ford ES. Does exercise reduce inflammation? Physical activity and C-reactive protein among US adults. Epidemiology 2002;13:561-568.
47. Wearden AJ, Morriss RK, Mullis R, et al. Randomised, double-blind, placebo-controlled treatment trial of fluoxetine and graded exercise for chronic fatigue syndrome. Br J Psychiatry 1998;172:485-490.
48. Ferroni P, Basili S, Falco A, et al. Inflammation, insulin resistance, and obesity. Curr Atheroscler Rep 2004;6:424-431.
49. Vazquez LA, Pazos F, Berrazueta JR, et al. Effects of changes in body weight and insulin resistance on inflammation and endothelial function in morbid obesity after bariatric surgery. J Clin Endocrinol Metab 2004;90:316-322.
50. King DE, Mainous AG, Pearson WS. C-reactive protein, diabetes, and attendance at religious services. Diabetes Care 2002;25:1172-1176.
51. Borovikova LV, Ivanova S, Zhang M, et al. Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature 2000;405:458-462.
52. Imperato AK, Smiles S, Abramson SB. Long-term risks associated with biologic response modifiers used in rheumatic diseases. Curr Opin Rheumatol 2004;16:199-205.